Back to 
BAKER BROS. ADVISORS LP
BAKER BROS. ADVISORS LP
BMRNShowing 0 of 20 quarters
Position history for BAKER BROS. ADVISORS LP's holdings in BIOMARIN PHARMACEUTICAL INC
No. Baker Bros. Advisors exited its BMRN (Biomarin Pharmaceutical) position in Q4 2023. Its Q3 2023 13F listed 3,810,248 shares worth $337.1M. Baker Bros. Advisors already held BMRN in its Q1 2019 13F, the earliest on record, and held it in 19 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of BMRN: Capital Research Global Investors, PRIMECAP MANAGEMENT CO/CA/, BlackRock Finance, Inc.